Randomised clinical trial to evaluate postoperative quality of life and body weight loss with the use of EPA-enriched nutrient for resectable gastric cancer patients

Phase 2

• Conditions: gastric cancer

• Registration Number: JPRN-UMIN000010568
• Lead Sponsor: Jichi Medical University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-23
• Study Completion: 2014-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

Not provided

Exclusion Criteria

1. reduced oral intake 2. Treated with icosapentate ethyl 3. supplements containing eicosapentaenoic acid 4. synchronous or metachronous cancer 5. lactate intolerance or allergic reaction to milk/soy 6. hemorrhagic tendency 7. uncontrolled diabetes mellitus 8. Systemic treatment with corticosteroids 9. unstable angina or cardiac infarction within 6 months 10. pulmonary disease under oxygenation 11. Woman with ongoing pregnancy or breast-feeding, or contemplating pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body weight loss and QOL score at 1/2/3/6 months after surgery

Secondary Outcome Measures

Name	Time	Method
postoperative functional disorder, lean body mass and skeletal muscle volume at 1/2/3/6 months after surgery, relative performance of Prosure, incidence of surgical morbidity.